Filing Details
- Accession Number:
- 0001104659-23-119962
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-11-20 17:00:07
- Reporting Period:
- 2023-11-16
- Accepted Time:
- 2023-11-20 17:00:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1356576 | Supernus Pharmaceuticals Inc. | SUPN | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1005544 | Iii W Charles Newhall | C/O Supernus Pharmaceuticals, Inc. 9715 Key West Avenue Rockville MD 20850 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-11-16 | 7,457 | $9.24 | 119,589 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-11-16 | 2,500 | $28.01 | 117,089 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Director Stock Option (Right to Buy) | Disposition | 2023-11-16 | 7,457 | $0.00 | 7,457 | $9.24 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2015-01-21 | 2024-01-21 | No | 4 | M | Direct |
Footnotes
- Represents the number of shares of common stock sold to cover the exercise price of the employee stock options.
Billionaire Hedge Funds
